window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-29484371-30');
Saturday , February 23 2019
Bordertown Undergroun Show 728
STEP 728
RHINOS 2018-2019 728
Home | Tag Archives: whooping cough

Tag Archives: whooping cough

Health Dept: Possible Whooping Cough Exposure at Austin High School

The City of El Paso Department of Public Health is working with officials at Austin High School to notify parents, students, teachers, and staff that they may have been exposed to a student with pertussis, also known as whooping cough.

“We don’t want to create alarm or panic for anyone involved in this possible exposure, but we do want to make sure that children, their parents, and any adults affected, recognize the importance of following the recommendations mentioned in the letter,” said Robert Resendes, Public Health Director.

Letters are being sent home to parents, and health officials are asking that students take great care in making sure the letters are reviewed in detail.

The letter suggests that they contact their primary care provider to let the doctor know that they may have been exposed to pertussis and to ensure that they are up-to-date with their vaccines. A physician should see anyone with a cough. If they are diagnosed with pertussis, they will be prescribed the appropriate antibiotic therapy. Anyone diagnosed should avoid public activities including school, sporting events, etc., until completion of a 5 day course of antibiotics.

Pertussis is a highly contagious bacterial infection that is spread through the air by coughing. Pertussis begins with cold-like symptoms and a cough which become much worse over one to two weeks.

Symptoms also usually include a long series of coughs (“coughing fits”) followed by a whooping noise. Intense coughing may be followed by vomiting, turning blue, or difficulty in catching one’s breath. There is generally no fever involved. The cough is often worse at night and cough medications usually do not help control the cough.

For more information on the programs and service provided by the Department of Public Health, call 2-1-1 or visit their website in English or Spanish.

UTEP Researchers Closer to Silencing Whooping Cough

A mother lovingly cradles her sick baby in her arms. As the infant coughs and gasps for air, his anguished mother looks up and warns that the safest place for your baby is not always in your arms.

The 30-second commercial by a pharmaceutical company encourages parents to get vaccinated against pertussis – a highly contagious respiratory disease also known as whooping cough. The disease affects people of all ages but can be especially serious, even fatal, for infants.

In 2015, more than 20,000 cases of whooping cough were identified in the United States. The Centers for Disease Control and Prevention estimate that there are 16 million pertussis cases worldwide.

“Pertussis is the only vaccine-preventable infection that still is endemic in the U.S. and worldwide,” said Delfina C. Domínguez, Ph.D., a UTEP professor of clinical laboratory sciences, who has studied pertussis for 10 years. “The disease is very severe in newborns and infants, who may die from the infection.”

Since 2014, Domínguez and XiuJun (James) Li, Ph.D., assistant professor in UTEP’s Department of Chemistry, have collaborated to develop a quicker and less invasive method to detect pertussis in medically underserved and low-resource settings. Recently, they completed testing the biochip on 100 clinical samples with excellent results.

Whooping cough can be difficult to diagnose because its symptoms resemble those of a cold or allergies. After two weeks, symptoms worsen, resulting in a hacking cough that sounds like a “whoop” when a person gasps for air.

Without proper diagnosis and treatment, symptoms may worsen and the infection can quickly spread to others through coughing and sneezing.

Current diagnosis methods are time consuming and require expensive equipment that may not be available in areas with limited access to medical supplies, equipment and medications.

This led Li to develop a paper-based three-dimensional microfluidic point-of-care (POC) device that integrates isothermal DNA amplification, a highly sensitive technique, to diagnose whooping cough.

Similar to a pregnancy test, the handheld device will use a sample from a nasal swab and change color to indicate the presence of the bacteria. Results will be available in less than an hour.

“A major benefit of this low-cost POC biochip is that it can be used in low-resourced settings such as primary care offices and in resource-limited countries to diagnose pertussis,” Li said.

Also known as lab-on-a-chip, microfluidic systems have made point-of-care testing more affordable and accessible, especially in developing nations.

Li expects the patent-pending technology to be available in schools, clinics and other limited-resource environments sometime in the near future.

“Using the innovative microfluidic lab-on-a-chip technique does away with the need for expensive specialized equipment that can cost up to $50,000,” Li said. “We estimate the cost of this device to be a few dollars.”

Li has designed and evaluated the effectiveness of the biochip using 100 clinical samples that Domínguez obtained from Children’s Hospital Los Angeles. So far, the results have been favorable.

“We found that the chip has high sensitivity and specificity and is comparable to real-time PCR – the technology used to diagnose infectious diseases in hospitals,” said Domínguez, who also is the co-investigator on a two-year grant that Li was awarded in 2015 from the National Institute of Allergy and Infectious Diseases to develop the technology.

The researchers also have been assisted by undergraduate and graduate students in Li’s laboratory, including Maowei Dou, Ph.D., who tested the device to see if it could successfully diagnose the Bordetella pertussis bacteria.

“The performance and testing results are very exciting, demonstrating great potential for disease diagnosis in low-resource settings,” said Dou, who worked on the project when he was a doctoral chemistry student at UTEP. He graduated in December 2016.

Dou’s research also was the basis for his dissertation titled, “Paper/polymer hybrid microfluidic biochips for infectious disease diagnosis.”

“As we know, infectious diseases are the leading cause of death in developing countries and often happen in high-poverty locations where the financial and medical resources are usually very limited,” said Dou, a postdoctoral researcher at Pacific Northwest National Laboratory. “I think it is very meaningful to carry out such research projects by developing low-cost point-of-care devices for low-resource settings.”

Li plans to continue testing the device using additional clinical pertussis samples. He also is developing microfluidic biochips for other infectious disease diagnosis such as meningitis.

Author:  Laura L. Acosta – UTEP Communications

Bordertown Undergroun Show 728
RHINOS 2018-2019 728
STEP 728